Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease

Cheng, Kun-LinKun-LinChengWang, Shao-WenShao-WenWangCheng, Yu-MingYu-MingChengHsieh, Tsung-HanTsung-HanHsiehWang, Chia-ChiChia-ChiWangJIA-HORNG KAO2024-01-122024-01-1220240929-6646https://scholars.lib.ntu.edu.tw/handle/123456789/638406In 2020, metabolic Associated Fatty Liver Disease (MAFLD) was proposed to replace non-alcoholic fatty liver disease (NAFLD) with new diagnostic criteria. The prevalence and clinical outcomes of MAFLD subtypes remained unclear.enAtherosclerosis; Liver fibrosis; Metabolic associated fatty liver disease; Non-alcoholic fatty liver disease; Subtype[SDGs]SDG3Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver diseasejournal article10.1016/j.jfma.2023.07.010374911792-s2.0-85165636196https://api.elsevier.com/content/abstract/scopus_id/85165636196